Cell No. : Cell Name
RCB4917 : HeLa/Fucci(SA)5#16
update : 2025/01/15
|
Comment | Important notice regarding nomenclature of Fucci. Research tools : Fucci – Fluorescent Ubiquitination-based Cell Cycle Indicator. |
Comment from the depositor | a subclone of HeLa.S3 cells provided by Dr. Mikoshiba in 2009. |
Terms and conditions | 1)If the BIOLOGICAL RESOURCE is to be used by a for-profit organization, the RECIPIENT must agree with RIKEN Innovation Co., Ltd. on the terms and conditions of its use. For inquiries, please contact : license-contact@innovation-riken.jp 2) The RECIPIENT’s Scientist agrees not to transfer the BIOLOGICAL RESOURCE and its derivatives to any third party including any resource center without the prior written consent of DEPOSITOR. 3) When publishing the research results obtained using the BIOLOGICAL RESOURCE, a citation to the literature specified by the DEPOSITOR or an acknowledgement to the DEPOSITOR is requested. Ando, R. et al., bioRxiv doi: 10.1101/2020.03.30.015156 (2020). |
Remarks | |
Order Form |
Order Form(C-0005.pdf)
 
MTA(C-0007.pdf)
 
|
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
|
|
Basic information
|
Depositor |
Miyawaki, Atsushi
|
Originator |
Miyawaki, Atsushi
|
Year of deposit |
2017
|
Another name |
HeLa/Fucci5#16
|
Original cell |
HeLa.S3
|
Cloning (depositor) |
Yes
|
Animal |
_human
< Mammals
|
Genus |
Homo
|
Species |
sapiens
|
Gender |
Female
|
Tissue |
cervical
|
Disease name |
cervical carcinoma
|
Classification |
cancer
|
Recombinant |
recombinant
|
Exogene |
tFucci(SA)5
|
|
Lifespan |
infinite
|
Morphology |
epithelial-like
|
Cellosaurus(Expasy) |
CVCL_A7AV
|
| |
deposit info |
lot info |
|
Medium |
Medium List |
|
Culture type |
Adherent cells
|
Adherent cells
|
Culture medium |
DMEM (low glucose) + 10% FBS
|
DMEM (low glucose) + 10% FBS
|
Antibiotics |
penicillin/streptomycin
|
Free
|
|
Passage method |
|
0.25% Trypsin
|
Culture information
|
Passage ratio |
|
1 : 8 split
|
SC frequency |
|
Subculture : 2 times/week
|
Temperature |
37
℃
|
37
℃
|
CO2 concentration |
5
%
|
5
%
|
Freeze medium |
|
Medium + 10% DMSO
|
Freezing method |
|
Slow freezing
|
Mycoplasma/Acholeplasma |
|
(-)
|
Animal PCR |
|
OK
|
STR(human) |
|
OK
|
Images |
deposit info | lot info |
|
|
Reference information |
Reference |
1
|
User's Publication |
3
|
User's Publication |
22125
Nojima H, Kaida A, Matsuya Y, Uo M, Yoshimura RI, Arazi L, Miura M.
DNA damage response in a 2D-culture model by diffusing alpha-emitters radiation therapy (Alpha-DaRT)
Sci Rep
2024
14(1):11468
PubMed ID: 38769339
DOI: 10.1038/s41598-024-62071-6
|
15096
Tohyama K, Kaida A, Miura M.
Determination of Clonogenic Radiosensitivity of HeLa Cells in Early and Late G1 Phases
Anticancer Res
2022
42(11):5407-5413
PubMed ID: 36288874
DOI: 10.21873/anticanres.16045
|
13371
Shimono H, Kaida A, Homma H, Nojima H, Onozato Y, Harada H, Miura M.
Fluctuation in radioresponse of HeLa cells during the cell cycle evaluated based on micronucleus frequency.
Sci Rep
2020
PubMed ID: 33257719
DOI: 10.1038/s41598-020-77969-0
|